Growth Metrics

Pharma-Bio Serv (PBSV) Leases (2012 - 2025)

Pharma-Bio Serv posted quarterly Leases of $29388.0 for Q4 2025, down 85.2% year-on-year from $198597.0 in Q4 2024, and down 59.6% on a QoQ basis from $72747.0 in Q3 2025.

Pharma-Bio Serv (PBSV) has 12 years of Leases data on file, last reported at $29388.0 in Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 85.2% year-over-year to $29388.0; the trailing twelve-month figure through Oct 2025 stood at $29388.0 (down 85.2% YoY), and the FY2025 full-year result was $29388.0, down 85.2% from the prior year.
  • Leases for Q4 2025 stood at $29388.0, down from $72747.0 in the prior quarter.
  • Across five years, Leases topped out at $790561.0 in Q1 2021 and bottomed at $29388.0 in Q4 2025.
  • The 5-year median for Leases is $412419.0 (2023), against an average of $409359.8.
  • The widest annual swing landed in 2021, when Leases declined 12.97%; it then slumped 85.2% in 2025.
  • A 5-year view of Leases shows it stood at $639969.0 in 2021, then fell by 21.45% to $502685.0 in 2022, then decreased by 29.09% to $356450.0 in 2023, then slumped by 44.28% to $198597.0 in 2024, then plunged by 85.2% to $29388.0 in 2025.
  • The last three Leases figures came in at $29388.0 (Q4 2025), $72747.0 (Q3 2025), and $115259.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 75.63 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 173.33 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 34.58 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 5.96 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 7.14 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 11.87 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 58.39 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 8.31 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 22.95 Mn
10 Pharma-Bio Serv - - 722,374.00 -

Historic Data

Download Data 🔒
DateValue
Oct 31, 2025 29,388.00
Jul 31, 2025 72,747.00
Apr 30, 2025 115,259.00
Jan 31, 2025 157,211.00
Oct 31, 2024 198,597.00
Jul 31, 2024 239,183.00
Apr 30, 2024 278,989.00
Jan 31, 2024 318,159.00
Oct 31, 2023 356,450.00
Jul 31, 2023 394,003.00
Apr 30, 2023 430,835.00
Jan 31, 2023 467,254.00
Oct 31, 2022 502,685.00
Jul 31, 2022 538,957.00
Apr 30, 2022 572,825.00
Jan 31, 2022 606,421.00
Oct 31, 2021 639,969.00
Jul 31, 2021 721,564.00
Apr 30, 2021 756,139.00
Jan 31, 2021 790,561.00
Oct 31, 2020 846,714.00
Jul 31, 2020 841,067.00
Apr 30, 2020 874,840.00
Jan 31, 2020 908,399.00
Oct 31, 2018 77,470.00
Oct 31, 2017 77,470.00
Oct 31, 2016 118,790.00
Oct 31, 2015 118,790.00
Oct 31, 2013 200,158.00
Oct 31, 2012 200,158.00